Cannabidiol Acid - CBDa
In industrial cannabis varieties (THC <0.2%), the predominant cannabinoid is cannabidiolic acid (CBDa), a precursor non-psychotropic substance that is converted to cannabidiol (CBD) when we process and heat cannabis.
CBDA is not an inactive form of CBD, it has though autonomous therapeutic potential and properties. Scientific studies have shown that CBDa works in addition to CBD and has a strong anti-inflammatory and anxiolytic effect, has analgesic effects, acts against nausea, has antiemetic properties, while recent research shows that it inhibits the metastasis of extremely aggressive cancer cells.
Scientific research has proven that CBDa is several times more potent than CBD and more bio-absorbable by the skin. In a recent medical study, administration of CBDa (0.1 μg / kg to 100 μg / kg) similarly reduced anxiety reactions in patients receiving CBD (5 mg / kg). This is 5,000 times less CBDa compared to CBD, achieving an equally strong therapeutic response.
Recent data also show that CBDa can actually help the body metabolize CBD better and that taking CBDa can reduce the amount of CBD needed to achieve the same effect.
There has been a growing trend recently, towards making juice from raw hemp leaves and flowers to get a satisfactory daily dose of CBDa.
KANNABIO CARE CROPS 3% full spectrum oil extract contains the ideal CBDa / CBD ratio 2: 1, dramatically increasing the bioavailability of the preparation.
